LSL/MED/0253 The Supply of Nalaxone and Atropine

UK2Preliminary market engagement notice094265-2026LLLEIDOS SUPPLY, LIMITED
16 days left
Estimated value£400,000
Deadline16 days left6 Nov 2026, 23:59
Competition00 participants
Lots11 lot

Keep momentum on this opportunity

Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.

  • Save and reuse search filters
  • Track opportunities as pursuits
  • Get notified when new notices match
Quick actions

Keep this notice in a shortlist so you can return to it without starting a bid.

Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.

Receive alerts

Key information

Identifier
Contract type
—
Deadline
6 Nov 2026, 23:59
CPV codes
33000000 - Medical equipments, pharmaceuticals and personal care products33140000 - Medical consumables33600000 - Pharmaceutical products
Status
Planning
Notice type
UK2Preliminary market engagement notice
Estimated value
£400,000
Publication date
6 Oct 2026, 12:28

Overview

In April 2015 the MOD signed a thirteen year contract with Leidos Europe Ltd to provide the procurement and inventory management of commodity items (as well as the storage and distribution services) historically provided in-house by the Logistic Commodities and Services Operating Centre. Leidos, working with the MOD, will transform the way these services are delivered to ensure requirements continue to be met whilst providing best value for money for the department. The organisation delivering these services is known as Team Leidos. Team Leidos would like to make markets aware that we are intending to investigate innovative approaches to fill our Supply of Naloxone and Atropine requirements. We are interested in the following: Atropine: Preferred product would be 2mg/mL in a 50mL vial, but the key requirement is the 100mg of drug in one vial. Naloxone: Preferred product would be 2mg/mL in a 20mL vial. However, would accept 2mg/ml in 50ml vial (total dose of 100mg per vial). It is the aim of this Preliminary Market Engagement Notice (PMEN) to encourage companies, suppliers, or manufacturers to make us aware and provide as much information as they are comfortable with, to help decide the future strategy for the range. Team Leidos wishes to generate interest, information and views with other companies to understand the current market innovation and gain useful intelligence that can help our requirement. To request the PMEN documents please contact: Name and Email address Macy Johnson [email protected] In the email request the documents related the Supply of Naloxone and Atropine. The documents will then be sent for completion and should be returned to the same email addresses before the deadline. Responses are required as soon as possible to inform next steps, but the PMEN will remain open until 06/11/2026

Procurement Act 2023

To request the PMEN documents please contact: Name and Email address Macy Johnson [email protected] Request the documents related to the Supply of Naloxone and Atropine. The documents will then be sent for completion and should be returned to the same email addresses before the deadline. Responses are required as soon as possible to inform next steps, but the PMEN will remain open until 06/11/2026

Contracting authorities1

LL

COH 09353172

gbBristol, United Kingdom
[email protected]

Lots1

Documentation0

Documents have not been synced yet. Last checked 21 Oct 2026, 22:51.

Award criteria0

No procedure-level award criteria recorded.

Participants0

No participants recorded for this notice.